Which antidepressant is known for its potential stimulant effects while addressing depression?

Bupropion is recognized for its stimulant effects while effectively treating depression. It is classified as an atypical antidepressant and primarily works as a norepinephrine-dopamine reuptake inhibitor (NDRI). This mechanism can enhance mood and energy levels, making it a suitable option for individuals who experience fatigue or low energy linked to their depressive symptoms. Moreover, unlike many other antidepressants, Bupropion does not typically cause sexual side effects or weight gain, which further makes it appealing to many patients.

The other options, while effective for depression, do not share the same stimulant profile. Duloxetine, for example, is a serotonin-norepinephrine reuptake inhibitor (SNRI) that primarily addresses both anxiety and depression but is more commonly associated with sedation rather than stimulation. Fluvoxamine is primarily used for obsessive-compulsive disorder as a selective serotonin reuptake inhibitor (SSRI) and is known for its calming effects. Sertraline, another SSRI, effectively treats depression but similarly lacks the stimulating properties characteristic of Bupropion.